The Discounted Cash Flow (DCF) valuation of Interpace Biosciences Inc (IDXG) is 7.28 USD. With the latest stock price at 0.90 USD, the upside of Interpace Biosciences Inc based on DCF is 713.0%.
Based on the latest price of 0.90 USD and our DCF valuation, Interpace Biosciences Inc (IDXG) is a buy. buying IDXG stocks now will result in a potential gain of 713.0%.
| Range | Selected | |
| WACC / Discount Rate | 5.8% - 31.5% | 18.6% |
| Long-term Growth Rate | 3.0% - 4.8% | 3.9% |
| Fair Price | 3.45 - 121.20 | 7.28 |
| Upside | 285.8% - 13442.4% | 713.0% |